National immunohistochemistry standardization program - establishment & launch - the overarching goal of this project is to change laboratory practice in the clinical immunohistochemistry (IHC)…
Ended Project Grant Awarded Last action
- Award ID
- R44CA268484
- Recipient
-
Boston Cell Standards Inc. UEI HA17F32KXEV8
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $1,999,519
Award facts
- Assistance listing
- 93.394 Cancer Detection and Diagnosis Research
- Completion date
- Originally
- Place of performance
- Massachusetts, USA
Award details come from USAspending.gov.
Description
National immunohistochemistry standardization program - establishment & launch - the overarching goal of this project is to change laboratory practice in the clinical immunohistochemistry (IHC) laboratory. IHC is the only clinical laboratory discipline without reference standards and traceable units of measure. This is despite the fact IHC is a major testing format in surgical pathology; a typical hospital IHC lab has a test menu of approximately 200 different tests. As a result, IHC analytic error rates range from 10 - 30% as compared to…
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $898,163 | |
| Original award | $1,101,356 |
Quick answers
Who received award R44CA268484?
R44CA268484 was awarded to Boston Cell Standards Inc. by National Cancer Institute (National Institutes of Health) on September 21, 2021.
How much is award R44CA268484 worth?
$1,999,519 has been obligated on R44CA268484.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award